The study provides thefirst evidence of the antiproliferative activity of Ocotea villosa (Kosterm) crude leaf extract (CE)against MCF-7, an estrogen receptor-positive (ER+) breast cancer cellline, the most predominant tumor subtype. This evidence concerns the gene ESR1 and breast cancer.